These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26434870)

  • 1. Nuclear DNA Damage and Repair in Normal Ovarian Cells Caused by Epothilone B.
    Rogalska A; Marczak A
    Asian Pac J Cancer Prev; 2015; 16(15):6535-9. PubMed ID: 26434870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epothilone B induces human ovarian cancer OV-90 cell apoptosis via external pathway.
    Rogalska A; Marczak A
    Environ Toxicol Pharmacol; 2015 Mar; 39(2):700-12. PubMed ID: 25721485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of epothilone B-induced cell death in normal ovarian cells.
    Rogalska A; Gajek A; Marczak A
    Cell Biol Int; 2013 Dec; 37(12):1330-9. PubMed ID: 23955989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of apoptotic pathway in normal, cancer ovarian cells by epothilone B.
    Rogalska A; Szula E; Gajek A; Marczak A; Jóźwiak Z
    Environ Toxicol Pharmacol; 2013 Sep; 36(2):600-610. PubMed ID: 23838010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epothilone B induces extrinsic pathway of apoptosis in human SKOV-3 ovarian cancer cells.
    Rogalska A; Gajek A; Marczak A
    Toxicol In Vitro; 2014 Jun; 28(4):675-83. PubMed ID: 24583341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epothilone B enhances surface EpCAM expression in ovarian cancer Hey cells.
    Shahabi S; Yang CP; Goldberg GL; Horwitz SB
    Gynecol Oncol; 2010 Nov; 119(2):345-50. PubMed ID: 20674962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone.
    Roque DM; Bellone S; Buza N; Romani C; Cocco E; Bignotti E; Ravaggi A; Rutherford TJ; Schwartz PE; Pecorelli S; Santin AD
    Am J Obstet Gynecol; 2013 Jul; 209(1):62.e1-9. PubMed ID: 23583215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of autophagy enhances preferential toxicity of epothilone A and epothilone B in ovarian cancer cells.
    Rogalska A; Gajek A; Marczak A
    Phytomedicine; 2019 Aug; 61():152847. PubMed ID: 31029905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epothilone B enhances Class I HLA and HLA-A2 surface molecule expression in ovarian cancer cells.
    Pellicciotta I; Yang CP; Goldberg GL; Shahabi S
    Gynecol Oncol; 2011 Sep; 122(3):625-31. PubMed ID: 21621254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest.
    Kamath K; Jordan MA
    Cancer Res; 2003 Sep; 63(18):6026-31. PubMed ID: 14522931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential responses of mitotic spindle pole formation to microtubule-stabilizing agents epothilones A and B at low concentrations.
    Sakaushi S; Nishida K; Fukada T; Senda-Murata K; Oka S; Sugimoto K
    Cell Cycle; 2008 Feb; 7(4):477-83. PubMed ID: 18235240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patupilone-induced apoptosis is mediated by mitochondrial reactive oxygen species through Bim relocalization to mitochondria.
    Khawaja NR; Carré M; Kovacic H; Estève MA; Braguer D
    Mol Pharmacol; 2008 Oct; 74(4):1072-83. PubMed ID: 18593821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B.
    Rogalska A; Marczak A; Gajek A; Szwed M; Śliwińska A; Drzewoski J; Jóźwiak Z
    Toxicol In Vitro; 2013 Feb; 27(1):239-49. PubMed ID: 22995584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epothilone B induces glioblastoma cell death via survivin down-regulation.
    Quick QA
    Exp Oncol; 2008 Sep; 30(3):195-201. PubMed ID: 18806741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha related gene response to Epothilone B in ovarian cancer.
    Khabele D; Lopez-Jones M; Yang W; Arango D; Gross SJ; Augenlicht LH; Goldberg GL
    Gynecol Oncol; 2004 Apr; 93(1):19-26. PubMed ID: 15047209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of patupilone in epithelial ovarian cancer and future directions.
    Rogalska A; Marczak A
    Life Sci; 2018 Jul; 205():38-44. PubMed ID: 29727613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A highly epothilone B-resistant A549 cell line with mutations in tubulin that confer drug dependence.
    Yang CP; Verdier-Pinard P; Wang F; Lippaine-Horvath E; He L; Li D; Höfle G; Ojima I; Orr GA; Horwitz SB
    Mol Cancer Ther; 2005 Jun; 4(6):987-95. PubMed ID: 15956256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas.
    Seagle BL; Yang CP; Eng KH; Dandapani M; Odunsi-Akanji O; Goldberg GL; Odunsi K; Horwitz SB; Shahabi S
    Gynecol Oncol; 2015 Jul; 138(1):159-64. PubMed ID: 25958320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspases and ROS - dependent mechanism of action mediated by combination of WP 631 and epothilone B.
    Rogalska A; Bukowska B; Marczak A
    Anticancer Agents Med Chem; 2014; 14(9):1261-70. PubMed ID: 24913659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epothilone-paclitaxel resistant leukemic cells CEM/dEpoB300 are sensitive to albendazole: Involvement of apoptotic pathways.
    Khalilzadeh A; Wangoo KT; Morris DL; Pourgholami MH
    Biochem Pharmacol; 2007 Aug; 74(3):407-14. PubMed ID: 17560963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.